晨光生物 (300138.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

22.8x

EV/EBITDA

13.3x

Market Cap

CNY 5.29B

MomentumView details →

1D Return

−0.18%

YTD Return

−3.06%

RSI (14)

61.9

ValuationView details →

P/E (Fwd)

22.8x

EV/EBITDA

13.3x

Market Cap

CNY 5.29B

RSI (14)

61.9

MomentumView details →

1D Return

−0.18%

YTD Return

−3.06%

ProfitabilityView details →

Gross Margin

12.97%

Net Margin

5.50%

EBITDA Margin

9.58%

ROE (TTM)

10.26%

ROA (TTM)

3.21%

Asset Turnover

0.63x

GrowthView details →

Revenue YoY

−7.26%

EPS YoY

+121.00%

FCF YoY

—

Revenue CAGR 3Y

+1.37%

EPS CAGR 3Y

−2.14%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

CNY 0.17

EPS Surprise

−21.33%

Beats (12Q)

0/12

Next Q EPS Est

CNY 0.21

Avg Surprise (4Q)

−21.33%

Rev Surprise

−1.06%

Capital & dividendView details →

Debt/Equity

1.63x

Current Ratio

1.24x

Quick Ratio

0.69x

Div Yield

2.49%

Div Rate

CNY 0.30

Div Growth 1Y

+130.77%

Financials snapshotView financials →

Revenue (TTM)

6.47B

Net Income (TTM)

356.11M

Op. CF (TTM)

−40.68M

Next earningsOct 27, 2026 →

Latest newsMore news →

Chenguang Biotech announced that as of August 31, 2026, it had repurchased 925,900 shares of its own stock for a total of 10.35 million yuan.4d ago

Chenguang Biotech Group announced its 2026 first-half results, with net profit attributable to shareholders of 179 million yuan, down 16.95% year-on-year.12d ago

Similar companies

鸿博股份002229.SZ 美瑞新材300848.SZ 永贵电器300351.SZ 南方精工002553.SZ 崇德科技301548.SZ 征和工业003033.SZ Find similar companies →

Latest newsMore news →

Chenguang Biotech announced that as of August 31, 2026, it had repurchased 925,900 shares of its own stock for a total of 10.35 million yuan.4d ago Chenguang Biotech Group announced its 2026 first-half results, with net profit attributable to shareholders of 179 million yuan, down 16.95% year-on-year.12d ago